Skip to main content
KimeraCHEMS
Display
3D molecular model of KIMERA-VASC™

These are separate references for the selectable peptide variants, not a blend of all variants and not one covalent peptide–carrier complex. GHK is shown without copper; the full platform composition is not modeled.

Heterogeneous mixture. SBE-β-CD is a distribution of substitution isomers, not one exact molecular structure. The carrier has no single source-assigned graph in this display.

Calculated reference model · not an experimental or batch-certified structure. All 24 atoms shown.

Model data & sources
  • Copper-free GHK reference for the named GHK platform variant; not substituted with GHK-Cu.
  • Heavy atoms only; hydrogens are omitted from the reference display.
  • Source-defined atom stereochemistry is checked against the calculated coordinates; no energy-minimum or observed-fold claim is made.
  • Reference molecular species only; batch counterions, excipients and material composition are not certified.
Sequence
GHK
Formula
C14H24N6O4
Method
RDKit ETKDGv3 / MMFF94s calculated reference conformer

KIMERA-VASC™

KIMERA-VASC™ (Two-Component Vascular Research Platform)

KIMERA-VASC™ is a modular two-component research platform engineered for vascular studies. The system pairs a cyclodextrin derivative (Sulfobutylether β-cyclodextrin) with a selectable peptide, providing a flexible framework for modeling complex biological conditions in an in vitro environment. By allowing researchers to modulate lipid environments while simultaneously introducing specific signaling cues, this platform enables highly controlled experimental design for investigating vascular cell responses and signaling interactions.

Additional Properties

Property Specification
System Components Sulfobutylether β-cyclodextrin (SBE-β-CD) + Selectable Peptide
Platform Class Modular in vitro vascular research system
Appearance Lyophilized powder

Research Applications

The KIMERA-VASC™ platform facilitates the creation of integrated models to study vascular biology and cellular signaling.

Primary fields of in vitro laboratory investigation include:

  • Lipid Stress Modeling: Utilizing SBE-β-CD to systematically alter membrane cholesterol content in cell cultures.

  • Signaling Pathway Interaction: Observing how peptide-based signaling cues function within a modified lipid environment.

  • Comparative Signaling Studies: Modulating the peptide component to assess different biological contexts or competitive signaling interactions.

  • Vascular Cell Assays: Application in endothelial or smooth muscle cell models.

  • Mechanistic Adaptation Research: Studying cellular responses to combined environmental and signaling modifications.

Storage & Handling Guidelines

Store at controlled room temperature, sealed and protected from light.

Storage guidance is a house recommendation. Analytical documentation is per-lot release testing.

Related Research Compounds

Research Use Disclaimer

Research Use Only Disclaimer: This product is labeled and sold "For Research Use Only — NOT FOR HUMAN CONSUMPTION." It is not a drug, dietary supplement, food, cosmetic, or medical device, and it is not approved by the FDA or any other regulator for human or veterinary use. It is supplied to approved account holders as a research chemical for laboratory use and must be handled in accordance with applicable law.

Kimera Chems

Compounds That Survive Scrutiny

Research use only. Not for human or veterinary use.